Driving your company forward: The future of generics in Europe

• Hear a comprehensive overview of the current pharma market from one of the leading companies in Central and Eastern Europe
• Understand the challenge of extending modern therapies into primary care and its potential as a growth driver
• Is there a model for profitable and sustainable financial growth in the region?

VP Commercial, Zentiva

• Discovery how to avoid the full risk of decreasing profitability in the European generics market
• Learn how the generic-plus products in your portfolio can disperse customer influence and increase your bottom line
• Find out the most useful and effective value added properties for generics

Area Director Europe, TAD Pharma

Meet customer demand: Value added delivery systems for generic Injectables

• Understand the different types of value added delivery systems for generic Injectables
• What drives the need for value added delivery systems: customers and company perspective
• How do customers value the value added approach and is it a profitable model for you?

Marketing Director Injectables EMEA, Hospira Healthcare

• Hear the new opportunities that generics-plus presented to Stada and could offer you in the Spanish market
• Find out how generics-plus drugs have been successfully marketed there, and margins increased through this campaign
• How this strategy could be successfully applied to other European countries so that your revenues are raised

Director of Marketing and Sales, Stada

• How hospital generic pricing was affected by the introduction of national procurement contacts and how to manage the accelerating pace of price erosion
• Are reverse E-auctions to be embraced or avoided?
• Know about the critical nature of new product introductions and their impact on future strategy - volume & velocity
• An evaluation of the increasingly important role of niche generics

National Sales Manager, Wockhardt

Case Study
Without motivation Columbus wouldn’t have discovered America – How you can motivate your ‘crew’ to achieve the common dream of smashing company targets

• Learn what the real potential of your field force is and how you can help them reach their full capacity as a key tool in driving up revenue
• How you can profile the development of your sales reps to ensure their effectiveness and value in achieving company targets
• Hear real results of what the key motivators are for pharmaceutical sales forces, so your

Country Manager Czech Republic, Belupo Pharmaceuticals

Create your marketing strategy with the pipeline in mind for increased efficiency

• What market intelligence should you have to ensure that you select the right portfolio and capitalise on market opportunities
• “Be first on the market,” is it the right strategy?
• Create a flexible business model for your operation to secure long term profitable business
• Ensure sales force effectiveness through affective pipeline management to increase revenue and efficiency
• Learn the impact of your strategic thrust and key decisions and to what extent this will affect portfolio planning

Sales & Marketing Manager Europe, Tabuk Pharmaceuticals

• Hear a comprehensive assessment of what strategy is really for, and how a radical shake up of existing ideas can radicalize your sales and marketing success
• How you can revolutionise your strategy using existing examples through cross-industry comparisons and gain a strategic edge in the generics market
• Discover solutions to major issues in strategy implementation and effective ways to monitor your strategy’s success to guarantee sharp and focused campaigns

General Manager Poland, Egis

Understand how to meet pan-European Challenges: European Union legislation and its attitude to generics

• Ways of improving the quality and dissemination of information on generics to citizens to enable them to make informed choices
• Do you really know European and national rules regarding pricing and reimbursement for generics?
• How to guarantee access to medicines at an affordable cost and ensure that medicines are safe and effective
• The challenge of balancing a high level of public health through cheaper drugs and innovation in the field of pharmaceuticals

Advisor, European Commission

Learn how to beat regulatory and legal problems in new EU member states to ensure a smooth transition and increase your sales

• What is the new pharma law and new patent law that comes into affect from the time of EU accession in January 2007?
• Hear about the impact of this major political and business environment change on the generics industry in these countries
• How to change the industry mindset and its business model orientation to adapt and thrive in a new environment
• Reformulate marketing and pricing strategies for achieving maximum sales effectiveness in this new situation

Executive Director, ABPhM

Winning profit in a commodity market: Is branding a necessity to increase revenues and improve your margins?

• An analysis of whether brands or commodities are the most profitable solution to decreasing margins, and whether you should be more concerned with margins or market share?
• Learn which direction actually gives more added value to customers and their patients
• Hear what the effects are on your company, depending which strategy you choose to focus on

General Manager Czech Republic, Teva

• Specifics of the OTC business & key influencers in its growth
• How to use your OTC drug profile to increase your company’s reputation in the market
• Understand regulatory affairs in mature & immature markets
• An analysis of the impact of generic OTC expenditure on the healthcare system

Associate Sales Manager, Deva Holding

• How to synergise your efforts in new markets and therapeutic areas through well chosen partnerships to reduce costs and increase efficiency
• Learn about creating mutual advantage to drive out branded pharma competition, lobby governments and educate clients
• Hear how such an approach can be achieved from one of Europe’s best examples

CEO, Clonmel Health

• Hear an overview of how the European regulatory system works for biosimilars
• Gain a comprehensive understanding of the European market through a comparative analysis to the American Market
• Find out how the first biosimilar was marketed and how others can follow

Head of Marketing and Sales Biopharmaceuticals, Sandoz

Panel Discussion: Effective strategies for operating in Europe now and in the future

• Know where to focus your sales and marketing efforts during this time of market consolidation and stop the squeeze of economies of scale
• Hear a prediction about where the market is heading in the near future and why this will be the case so you can stay ahead of the curve
• Learn how you can strategically position yourself now, to take full advantage of these changes for the future and keep your revenue growth healthy

Moderator: General Manager, Afarma
Panellist: CEO, Copyfarm
Plus 2 more top level executives!